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Background: Respiratory distress syndrome of the neonate (neonatal RDS) is still an important problem in treat-
ment of preterm infants. It is accompanied by inﬂammatory processes with free radical generation and oxidative
stress. The aim of study was to determine the role of oxidative stress in the development of neonatal RDS.
Methods:Markers of oxidative stress and antioxidant activity in umbilical cord bloodwere studied in infants with
neonatal respiratory distress syndrome with reference to healthy newborns.
Results: Status of markers of oxidative stress (malondialdehyde, protein carbonyl and 8-hydroxy-2-deoxy
guanosine) showed a signiﬁcant increase with depleted levels of total antioxidant capacity in neonatal RDS
when compared to healthy newborns.
Conclusion: The study provides convincing evidence of oxidative damage and diminished antioxidant defenses in
newborns with RDS. Neonatal RDS is characterized by damage of lipid, protein and DNA, which indicates the
augmentation of oxidative stress.
General signiﬁcance: The identiﬁcation of the potential biomarker of oxidative stress consists of a promising strat-
egy to study the pathophysiology of neonatal RDS.© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Oxidative stress is an imbalance between the systemicmanifestation
of reactive oxygen species and a biological system's ability to readily
detoxify the reactive intermediates or to repair the resulting damage.
It is a physiological event in the fetal-to-neonatal transition, which is
actually a great stress to the fetus. These physiological changes and
processes greatly increase the production of free radicals, which must
be controlled by the antioxidant defense system, the maturation of
which follows the course of the gestation. This could lead to several
functional alterations with important repercussions for the infants.
Adequately mature and healthy infants are able to tolerate this drastic
change in the oxygen concentration. A problem occurs when the
intrauterine development is incomplete or abnormal. Preterm or intra-
uterine growth retarded (IUGR) and low birth weight neonates are91 542236756.
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. This is an open access article undertypically of this kind [1,2]. An oxidant/antioxidant imbalance in infants
is implicated in the pathogenesis of the major complications of prema-
turity including respiratory distress syndrome (RDS), necrotizing en-
terocolitis (NEC), chronic lung disease, retinopathy of prematurity and
intraventricular hemorrhage (IVH).
In neonates born with respiratory distress syndrome, respiratory
failure due to deﬁcient alveolar development and surfactant production
could be complicated by diminished antioxidant stores and enzymatic
antioxidant inducibility. The premature newborn's lung is particularly
susceptible to oxidant stress because there are many sources of reactive
oxygen species (ROS) production and a relative lack of antioxidant
defenses. A fully developed lung armed with sufﬁcient defense is
therefore critical in ensuring that the newborn lung is resistant to high
O2 tensions.
Infant respiratory distress syndrome (IRDS), also called neonatal
respiratory distress syndrome or respiratory distress syndrome of
newborn, previously called hyalinemembrane disease (HMD), is a syn-
drome in premature infants caused by developmental insufﬁciency of
surfactant production and structural immaturity in the lungs. IRDS
affects about 1% of newborn infants and is the leading cause of death
in preterm infants [3]. When born too early, infants are delivered with
a very immature stage of lung development, the late canalicular stage
for infants born at 24–26 weeks (i.e., for ELBW infants), and early or
mild saccular stage for those born after 26 but before 32 weeks ofthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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[4]. Preterm birth occurring during the late canalicular or early saccular
stage is very likely to lead to severe respiratory distress syndrome
(RDS). The poorly developed peripheral airways and immaturity of
cells important for lungmaturation are themajor causes of poor surfac-
tant production by type II cells and inadequate antioxidant responses to
increased ambient oxygen. For instance, the superoxide dismutase
(SOD) activity appears in the developing lungs concomitantly with the
surfactant synthesis by type II pneumocytes [5].
When phagocytes such as neutrophils are stimulated by microor-
ganisms or other means, they become activated and increase their oxi-
dative metabolism; as a result, toxic oxygen and nitrogen derivatives,
i.e., ROS/RNS, are formed. If these toxic products are not inactivated,
their high chemical reactivity leads to damage to a variety of cellular
macromolecules including proteins, carbohydrates, lipids and nucleic
acid. This results in cell injury and may induce respiratory cell death
[6]. Under these conditions, a surfactant deﬁciency may be aggravated
by inactivation of the small amount of endogenous surfactant that is
produced [7]. Furthermore, if exogenous surfactant is given this may
also be destroyed [8,9].
An attempt has been made to investigate the alterations in the
biochemical parameters of oxidant/antioxidant by quantiﬁcation of
levels of 8-hydroxy-2-deoxy guanosine (8-OHdG), protein carbonyl
and malondialdehyde (MDA) along with total antioxidant capacity in
study subjects and healthy controls. Umbilical cord blood provides valu-
able information regarding the status of the infant at birth. Cord blood
parameters can be considered as early predictors of some of the
metabolic disorders in future adult life. Based on this concept, our
present observational study aims at evaluating the cord blood oxidative
stress parameters in newborns with respiratory distress syndrome and
provides a concise view of their current status among the healthy
newborns.2. Materials and methods
A case–control study was conducted in the Department of Biophys-
ics in collaboration with Department of Pediatrics, IMS, BHU, Varanasi.
Cord blood samples from a total of 36 pregnant women were collected
at the time of the delivery. The study group consisted of 16 preterm
low birth weight newborns with diagnosis of RDS. The control group
was composed of 20 preterm low birth weight newborns. All the sub-
jectswere selected from theDepartment of Obstetrics andGynaecology,
University Hospital, Banaras Hindu University (India). RDS was diag-
nosed on the presence of typical clinical and radiological signs of the dis-
ease in the preterm infants. Newborns were considered to have RDS if
they have tachypnea, grunting and cyanosis with several hours of
birth required mechanical ventilation and typical radiographic ﬁndings
on the chest X-ray. The diagnosis was established from the clinical
symptoms and needed for oxygen treatment.
Ethical approval and permission for the study was taken from
the Ethical Committee of Institute of Medical Sciences, Banaras
Hindu University (India). Informed consent was taken from the
patients/attendants from all the studied subjects purely for of re-
search purpose. With all aseptic precautions cord blood samples
(with and without heparin) of all studied subjects were collected.
The blood samples were centrifuged at 5000 rpm for 10 min and
plasma/serum was separated and stored at −20 °C. The samples
were assayed in triplicate for statistical purposes.
Exclusion criteria of the study were infection, hemolytic disease,
major malformations, hypertension disorder and newborns with histo-
ry of difﬁcult delivery, genetic disorder and fetal distress. The weight of
the newborn was recorded immediately after delivery in Secaweighing
scale with an accuracy of 5 g. Maternal age, height, weight, date of last
menstrual period, medical history and reproductive history were
obtained from the hospital record.2.1. Malondialdehyde—marker of lipid peroxidation
Plasma malondialdehyde (MDA) levels in the cases and controls
were assayed by thiobarbituric acid reactive substances (TBARS) tech-
nique of Philpot [10]. The sample (1 ml) was mixed thoroughly with
2 ml of TCA–TBA–HCl (15% w/v TCA and 0.375% w/v TBA in 0.25 N
HCl). The mixture was heated in a boiling water bath for 15 min. The
samples were centrifuged at 1000 rpm for 10 min. The absorbance of
the sample was determined at 530 nm in a spectrophotometer against
a suitable blank. The malondialdehyde concentration of each sample
was calculated by using extinction coefﬁcient of 1.56 × 105 M−1 cm−1.2.2. Protein carbonyl—marker of oxidative protein damage
Plasma protein carbonyl wasmeasured using spectrophotometric
DNPH method [11]. The assay is based on the spectrophotometric
detection of the reaction between 2,4-dinitrophenyl hydrazine
(DNPH) with protein carbonyl to form protein hydrazone. Carbonyl
content was determined as nmol/mg protein. The intra- and inter-
assay coefﬁcients of variations were 4.7% and 8.5%, respectively.
The total protein content was measured using colorimetric kit
based on biuret method [12].2.3. 8-OHdG—marker of oxidative DNA damage
Serum of all the cases and control samples was used for the
measurement of 8-OHdG levels using competitive in vitro enzyme-
linked immunosorbent assay (ELISA) kit obtained from Caymen Chem-
ical Company U.S.A.[13]. 8-OHdGmeasurements were performed using
microtiter ELISA plate pre-coated with anti-mouse IgG. 50 μl sample,
50 μl 8-OHdG AChE (Acetylcholinesterase) tracer and 50 μl 8-OHdG
monoclonal antibody were added to each well and incubated at 4 °C
for 18 h. After thewells were washed ﬁve times, 200 μl Ellman's reagent
was added to each well. The wells were incubated at room temperature
in the dark for 100 min. The absorbance was read at wavelength of
420 nm. ELISA assay displays IC50 (50% B/B0) and IC80 (80% B/B0) values
of approximately 100 and 30 pg/ml, respectively.2.4. Total antioxidant status (TAS)—marker of oxidative defense
The plasma total antioxidant status was determined using Randox
assay kit [14]. The assay was based on the principle that ABTS (2,2′-
Azino-di-[3-ethylbenzthiazoline sulphonate]) is incubated with a
peroxidase and H2O2 to produce the radical cation ABTS+. This has a
relatively stable blue green color, which is measured at 600 nm. Antiox-
idant in the cord blood causes the suppression of this color production
to a degree which is proportional to their concentration.2.5. Statistical analysis
Data were expressed as the mean ± SD. A chi-square test was used
for comparison of non-parametric data. An independent-sample t-test
was used for comparison of parametric variables. Logistic univariate
regression was chosen as inferential analysis, instead of multivariate
logistic regression for the lack of data, and it checked the relation
between the presence/absence at least one of disease as a dependent
variable and each oxidative stress marker as an independent variable.
Through the logistic model, it is possible to calculate estimated coefﬁ-
cients (B), standard error (SE),Wald statistic, signiﬁcance (p) and expo-
nential or odds ratio Exp(B) with the relative conﬁdence interval (95%
CI). p b 0.05 was considered as statistically signiﬁcant. The index risk
was calculated using the SPSS statistical software package (SPSS 16).
Table 1
Mother and neonatal characteristics of studied subjects.
Characteristics RDS group (N= 16) Control (N= 20) p
Maternal age (years) 27 ± 5 (24.51–29.61)⁎(24.51 – 29.61) 25 ± 4⁎(23.18–26.81)⁎ t= 1.427 (p= 0.163, NS)
Gravida
Primigravidas 6 (37.5%) 9 (45%) χ2 = 0.206 (p= 0.650, NS)
Multigravidas 10 (62.5%) 11 (55%)
Mode of delivery
Vaginal delivery 4 (25%) 7 (35%) χ2 = 0.419 (p= 0.517, NS)
Cesarean section 12 (75%) 13 (65%)
Sex
Males 6 (37.5%) 4 (20%) χ2 = 1.357 (p= 0.244, NS)
Females 10 (62.5%) 16 (80%)
Gestational age(weeks) 29.6 ± 1.5 (28.8–30.4)⁎ 34.6 ± 1.2 (34.1–35.2)⁎ t=−11.124 (p= 0.000)⁎⁎
Birth weight(g) 1120 ± 156 (1037–1023)⁎ 1725 ± 193 (1634–1815)⁎ t=−10.134 (p= 0.000)⁎⁎
Body mass index (BMI)
(kg/m2)
9.04 ± 2.06 (7.94–10.14)⁎ 9.17 ± 1.01 (8.70–9.64)⁎ t=−0.249 (p= 0.805, NS)
Apgar score
1 min 6.75 ± 1.34 (6.04–7.46)⁎ 8 (8–8)⁎ t=−4.182 (p= 0.000)⁎⁎
5 min 7.94 ± 1.12 (7.34–8.54)⁎ 9 (9–9)⁎ t=−4.254 (p= 0.000)⁎⁎
Data are presented as mean ± SD or as percentage.
p value-independent t or chi-square test as appropriate
NS = non-signiﬁcant; χ2 = Pearson chi-square; BMI = weight/height2.
⁎ 95% conﬁdence interval for mean (lower bound–upper bound).
⁎⁎ Signiﬁcant at p b 0.001.
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The low birthweight infants with RDSwere treated as cases and low
birth weight infants without RDS, who presented with no respiratory
manifestations served as control subjects.
Table 1 summarizes the characteristics of mothers and newborns
included in this study. The respiratory distress syndrome (RDS)
group composed of 16 preterm low birth weight newborns born
with a mean gestational age (GA) of 29.6 ± 1.5 weeks having a
mean birth weight 1120 ± 156 g. The control group composed of
20 preterm low birth weight newborns born with a mean GA of
34.6 + 1.2 weeks having a mean birth weight 1725 ± 193 g. The sta-
tistical analysis for comparison of non-parametric data between each
group was performed by chi-square test. The signiﬁcant difference of
parametric data was evaluated with Student's t-test with equal var-
iance. Newborns in RDS group were more premature and had
lower birth weight in comparison to control group. There was no sig-
niﬁcant difference in maternal age (p= 0.163), gravida (p= 0.650),
mode of delivery (p = 0.517), sex of newborn (p = 0.244) and BMI
(p = 0.805) between RDS and control group. The mean of Apgar
score in RDS group were signiﬁcantly lower (p b 0.001) than the
control.
Table 2 shows the concentration of oxidative damage markers and
the total antioxidant status in the umbilical cord blood of newborn
with respiratory distress syndrome in comparison to controls. The
signiﬁcant difference was evaluated with Student's t-test with equal
variance. The extent of protein oxidation and oxidative DNA damage
as evidenced by protein carbonyl and 8-OHdG, respectively, was signif-
icantly increased in the RDS group (p b 0.001) compared to control
subjects. The product of lipid peroxidation–MDA was signiﬁcantly
increased 43.46% in RDS group (p b 0.005) than that of control. ATable 2
Oxidative damage markers and total antioxidant status in different studied groups.
Damage markers Protein carbonyl (nmol/mg protein) MDA (mmol/l)
RDS group (N= 16) 4.535 ± 1.602 (3.682–5.389)⁎ 3.698 ± 1.516 (2.890
Control (N= 20) 2.663 ± 0.963 (2.212–3.114)⁎ 2.091 ± 1.062 (1.594
t-value (p) t= 4.345 (p= 0.000)⁎⁎ t= 3.736 (p= 0.001
Data are presented as mean ± SD.
⁎ 95% conﬁdence interval for mean (lower bound–upper bound).
⁎⁎ Signiﬁcant at p b 0.001.
⁎⁎⁎ Signiﬁcant at p b 0.005.signiﬁcant decrease in TAS (p b 0.001) was seen in the RDS group as
compared to control.
Table 3 shows the results of univariate logistic regression analysis to
estimate the association of oxidative damage markers and total
antioxidant status with incidence of respiratory distress syndrome in
newborns. The positive association of risk of RDS was observed with
protein carbonyl (OR = 0.249, p b 0.005), MDA (OR = 0.404, p b
0.005) and 8-OHdG (OR= 0.682, p b 0.05) with partial regression coef-
ﬁcient 1.389, 0.907 and 0.383, respectively. A signiﬁcant inverse correla-
tion of risk of RDS in study subjectswas foundwith TAS (OR=1.039, p b
0.005) with partial regression coefﬁcient −0.038. Logistic analysis
showed that the elevated level of protein carbonyl, MDA and 8-OHdG
might be risk factor, reduced level of total antioxidant status might
lead to the RDS in newborn.
4. Discussion
Neonatal respiratory distress syndrome represents the major lung
complications of newborn babies. Pretermneonates suffer from respira-
tory distress syndrome (RDS) due to immature lungs and require
assisted ventilation with high concentrations of oxygen. The pathogen-
esis of this disorder is based on the rapid formation of the oxygen
reactive species, which surpasses the detoxiﬁcation capacity of anti-
oxidative defense system [15,6]. The high chemical reactivity of free
radical leads to damage to a variety of cellular macro molecules includ-
ing proteins, lipids and nucleic acid. This results in cell injury and may
induce respiratory cell death [8].
Malondialdehyde (MDA) is one of the ﬁnal products of polyunsatu-
rated fatty acids peroxidation. The present study showed increased
concentration of MDA in neonates with respiratory disorders than that
of control in consonance with the reported study [16].8-OHdG (pg/ml) TAS (mmol/l)
–4.506)⁎ 39.60 ± 11.153 (33.657–45.543)⁎ 0.586 ± 0.281 (0.436–0.736)⁎
–2.588)⁎ 23.35 ± 7.609 (19.789–26.911)⁎ 1.241 ± 0.331 (1.087–1.396)⁎
)⁎⁎⁎ t= 5.187 (p= 0.000)⁎⁎ t=−6.304 (p= 0.000)⁎⁎
Table 3
Logistic regression analysis of the relation to biochemical parameters to respiratory
distress syndrome (RDS) in newborn infants.
Parameters B Odd ratio
(OR)
p 95% class interval (CI) of OR
(lower–upper)
Protein carbonyl 1.389 0.249 0.004⁎ 0.096–0.648
MDA 0.907 0.404 0.004⁎ 0.219–0.747
8nOHdG 0.383 0.682 0.021⁎⁎ 0.492–0.945
TIBC −0.038 1.039 0.017⁎⁎ 1.007–1.072
B= partial regression coefﬁcient.
⁎ Signiﬁcant at p b 0.005.
⁎⁎ Signiﬁcant at p b 0.05.
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present study observed elevated level of protein carbonyl in umbilical
cord blood of neonates with respiratory syndrome (RDS) compared to
control. Some studies also reported that prematurely born babies with
RDS showed high concentrations of protein carbonyls [17,18]. The
amount of oxidatively modiﬁed protein may provide a quantitative
assessment of oxygen toxicity and of pulmonary antioxidant defenses
[19]. Lung proteins are attacked by oxygen reactive species. When RDS
is present, pulmonary oedema occurs because of increased permeability
of cell membranes. The ﬂuid in the oedema is rich in proteins, which
represent the ideal target for oxygen reactive species. In order to initiate
the oxidative attack, oxygen reactive species inactivates alpha-1 prote-
ase, thus causing an imbalance in the lung protease–antiprotease sys-
tem [20,21]. Reactive oxygen species also interact with pulmonary
surfactant as well as with other protein and lipid structures, thus
delaying the normal functioning of the lung. Therefore, surfactant
administration before the initiation of mechanical ventilation dimin-
ishes the severity of lung lesions by providing consistent ventilation
[22]. This protein oxidation process activated by oxygen reactive species
has been proven to contribute to pathogenesis in newborns with RDS
[23,24]. The present study shows that neonates with RDS had higher
protein damage compared to control. Statistically signiﬁcant correla-
tions were observed between protein carbonyl value and the occur-
rence of RDS [25].
In present study, 8-OHdG was used as a sensitive marker for oxida-
tive DNA damage. 8-OHdG was higher in the umbilical cord blood of
neonates with RDS compared to control. Oxidative DNA damage could
be the crucial mechanism in the pathogenesis of respiratory disorder
[26].
Oxidative damage is important in the pathogenesis of respiratory
distress syndrome (RDS). It can be assumed that these newborns
might be at risk of an oxidative stress. One previous study [27] also
observed oxidative stress in neonates with respiratory distress syn-
drome. Reactive oxygen is generated by several inﬂammatory and
structural cells of the airways. These oxidant species have important
effects on a variety of lung cells as regulator of signal transduction,
activators of key transcription factors and modulators of gene ex-
pression and apoptosis. Thus, increased oxidative stress accompa-
nied by reduced antioxidant defenses may play a role in the
pathogenesis of a number of inﬂammatory pulmonary diseases in-
cluding RDS in the newborn [28].
The present study observed reduction in total antioxidant status in
newborns with RDS compared to healthy newborns. One study also
reported decreased level of total antioxidant activity in newborn with
RDS [29]. Oxidant–antioxidant balance shifts in favor of the oxidative
damage in premature newborns with RDS due to diminished antioxi-
dant activity. Antioxidant defenses of the immature lung will be
prepared neither for the hyperoxic environment nor the inﬂammation
found in association with respiratory distress. The lung depends on a
delicate balance between oxidant and antioxidant systems to maintain
normal cellular function. The lungs of prematurely born infants suffer-
ing from respiratory distress syndrome may be ill-adapted for protec-
tion against ROS. Antioxidants clearly have an important role in thedefense against free radical induced lung injury in newborns with
respiratory distress syndrome (RDS).
The present study showed that the elevated level of protein carbon-
yl, MDA and 8-OHdG, might be risk factor, reduced level of total antiox-
idant status might lead to the RDS in newborn. Total antioxidant status
might serve as prognosticmarker in newbornswith RDS andmight help
distinguish high risk infants. Neonatal respiratory distress syndrome is
accompanied by inﬂammatory processes with free radical generation
and oxidative stress [30,31]. The imbalance between the oxidative
forces and the antioxidant defense systemswas suggested to predispose
the lungs to the development of RDS [32,33]. Many studies have shown
increased oxidant stress markers and/or reduced antioxidant defense in
preterm infants with RDS [34,35].
5. Conclusion
The result of this study indicates that oxidative stresswas induced in
newbornswith RDSwhich ismanifested as increased lipid peroxidation,
protein oxidant damage and oxidative DNA damage. Thus, an increased
oxidative stress accompanied by reduced antioxidant defensesmay play
a role in the pathogenesis of respiratory distress in newborns.
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